Gabriela Johnson

Gabi is a Senior Research Associate at Yarrow focusing on therapeutic antibody discovery for autoimmune diseases and developing laboratory infrastructure.

As a scientist at Pfizer’s Centers for Therapeutic Innovation, Gabi worked on two drug development programs in oncology. Before that, she was a Research Assistant at Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute. Her research at MSKCC, on STING pathway’s role in metastasis was published in Nature, while her research at DFCI, on CDK4/6 inhibitor resistance in metastatic breast cancer was published in Cancer Discovery.

Gabi received her BS in Cell and Molecular Biology from Cornell University.